ISSN (Online): 2321-3418
server-injected
Medical Sciences and Pharmacy
Open Access

Idiopathic Pulmonary Fibrosis Associated with Pulmonary Hypertension: A Case Report on Diagnostic Challenges and Follow-Up Recommendations

DOI: 10.18535/ijsrm/v13i02.mp06· Pages: 1353-1357· Vol. 13, No. 02, (2025)· Published: February 14, 2025
PDF
Views: 371 PDF downloads: 155

Abstract

Background:

Idiopathic Pulmonary Fibrosis (IPF) is an insidious continuous interstitial lung disease presenting histologically with fibrous deposition, and the linings of alveolar sac in the lungs leading to respiratory failure. Pulmonary hypertension (PH) is one complication of IPF that often exacerbates symptoms and worsens prognosis. The association between IPF and PH still necessitates improved diagnostic approaches and tailored treatment approaches.

Case Presentation:

A 60-year-old male presented with complaints of severe dyspnea of severe dyspnea, tiredness, and orthopnea. Objective examination showed acrocyanosis, JVP elevation, and loud P2. On the chest radiograph and HRCT of the lungs, showed interstitial infiltrates with honeycombing and traction bronchiolectasis, which confirmed IPF. Echocardiogram and right heart catheterization confirmed PH, with the mean pulmonary arterial pressure recording at 45mmHg, while lung function tests showed decreased FVC, TLC and DLCO.

Outcome:

The patient was initiated on antifibrotic therapy, pirfenidone and pulmonary vasodilator (sildenafil). Over a six-month period, patient showed improvements in exercise capacity, dyspnea, and oxygenation. Prompt recognition and individualized treatment approach is needed in patient with pulmonary hypertension (PH) and idiopathic pulmonary fibrosis (IPF) progress.

Conclusion:

The patient herein highlights the importance of early identification and intervention of PH in IPF patients. A multidisciplinary approach with vasodilators and antifibrotic therapy are needed to improve symptoms, slow disease progression and improving on quality of life.

References

  1. Lynch, J. P. III, Huynh, R. H., & Fishbein, M. C. (2016). Idiopathic pulmonary fibrosis: Epidemiology, clinical features, prognosis, and management. Thieme Medical Publishers.Google Scholar ↗
  2. Retrieved from https://thieme-connect.comGoogle Scholar ↗
  3. Ryu, J. H., Colby, T. V., & Hartman, T. E. (1998). Idiopathic pulmonary fibrosis: Current concepts. Mayo Clinic Proceedings, 73(5), 451-457.Google Scholar ↗
  4. https://doi.org/10.1016/S0025-6196(11)63448-1DOI ↗Google Scholar ↗
  5. Noble, P. W., & Homer, R. J. (2004). Idiopathic pulmonary fibrosis: New insights into pathogenesis. Clinics in Chest Medicine, 25(4), 737-750.Google Scholar ↗
  6. https://doi.org/10.1016/j.ccm.2004.08.006DOI ↗Google Scholar ↗
  7. Lederer, D. J., & Martinez, F. J. (2018). Idiopathic pulmonary fibrosis. New England Journal of Medicine, 378(19), 1811-1823.Google Scholar ↗
  8. https://doi.org/10.1056/NEJMra1616348DOI ↗Google Scholar ↗
  9. Zisman, D. A., Keane, M. P., Belperio, J. A., Strieter, R. M., & Fishman, J. A. (2005). Pulmonary fibrosis. Research: Methods and Reviews, 41(5), 491-503.Google Scholar ↗
  10. https://doi.org/10.1007/978-1-4020-3065-0_31DOI ↗Google Scholar ↗
  11. Poletti, V., Ravaglia, C., Buccioli, M., Tantalocco, P., et al. (2013). Idiopathic pulmonary fibrosis: Diagnosis and prognostic evaluation. Respiration, 86(3), 180-191.Google Scholar ↗
  12. https://doi.org/10.1159/000350257DOI ↗Google Scholar ↗
  13. Lynch, J. P., & Mahidhara, R. (2016). Idiopathic pulmonary fibrosis. Interstitial Pulmonary Disease: A Textbook of Interstitial Lung Disease, 6, 302-318.Google Scholar ↗
  14. https://doi.org/10.1201/b16032-17DOI ↗Google Scholar ↗
  15. Coultas, D. B., & Hubbard, R. (2003). Epidemiology of idiopathic pulmonary fibrosis. Idiopathic Pulmonary Fibrosis, 14(1), 3-9.Google Scholar ↗
  16. https://doi.org/10.3109/00122130309029588DOI ↗Google Scholar ↗
  17. Munchel, J. K., & Shea, B. S. (2021). Diagnosis and management of idiopathic pulmonary fibrosis. Rhode Island Medical Journal, 104(6), 233-237.Google Scholar ↗
  18. Retrieved from https://rimed.orgGoogle Scholar ↗
  19. Swigris, J. J., Kuschner, W. G., Kelsey, J. L., Gould, M. K., & Stoller, J. K. (2005). Idiopathic pulmonary fibrosis: Clinical aspects and prognosis. Chest, 127(5), 2167-2175.Google Scholar ↗
  20. https://doi.org/10.1378/chest.127.5.2167DOI ↗Google Scholar ↗
  21. Sgalla, G., Biffi, A., & Richeldi, L. (2016). Idiopathic pulmonary fibrosis: Diagnosis, epidemiology, and natural history. Respirology, 21(5), 892-902.Google Scholar ↗
  22. https://doi.org/10.1111/resp.12752DOI ↗Google Scholar ↗
  23. Munchel, J. K., & Shea, B. S. (2021). Diagnosis and management of idiopathic pulmonary fibrosis: Implications for respiratory care. Respiratory Care, 66(1), 54-63.Google Scholar ↗
  24. https://doi.org/10.4187/respcare.07123DOI ↗Google Scholar ↗
  25. Du Bois, R. M. (2011). Idiopathic pulmonary fibrosis: Present understanding and future options. European Respiratory Review, 20(121), 166-171.Google Scholar ↗
  26. https://doi.org/10.1183/09059180.00007911DOI ↗Google Scholar ↗
  27. Oldham, J. M., & Noth, I. (2014). Idiopathic pulmonary fibrosis: Early detection and referral. Respiratory Medicine, 108(5), 696-705.Google Scholar ↗
  28. https://doi.org/10.1016/j.rmed.2013.12.020DOI ↗Google Scholar ↗
  29. Pérez, E. R. F., Daniels, C. E., Sauver, J. S., & Hartman, T. E. (2010). Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: A population-based study. Chest, 138(3), 625-633.Google Scholar ↗
  30. https://doi.org/10.1378/chest.09-3177DOI ↗Google Scholar ↗
  31. Prasad, R., Gupta, N., Singh, A., & Gupta, P. (2015). Diagnosis of idiopathic pulmonary fibrosis: Current issues. Intractable & Rare Diseases Research, 4(2), 52-60.Google Scholar ↗
  32. https://doi.org/10.14341/irdr2015139DOI ↗Google Scholar ↗
  33. Dempsey, O. J., Kerr, K. M., & Gomersall, L. (2006). Idiopathic pulmonary fibrosis: An update. Journal of the Royal College of Physicians of Edinburgh, 36(4), 275-280.Google Scholar ↗
  34. https://doi.org/10.4997/JRCPE.2006.400DOI ↗Google Scholar ↗
  35. Meier-Sydow, J., Weiss, S. M., & Buhl, R. (1994). Idiopathic pulmonary fibrosis: Current clinical concepts and challenges in management. Journal of Respiratory and Critical Care Medicine, 149(4), 1056-1065.Google Scholar ↗
  36. https://doi.org/10.1164/ajrccm.149.4.7515649DOI ↗Google Scholar ↗
  37. Oldham, J. M., Moua, T., & Daniels, C. E. (2014). Idiopathic pulmonary fibrosis: Evolving concepts. Mayo Clinic Proceedings, 89(4), 516-528.Google Scholar ↗
  38. https://doi.org/10.1016/j.mayocp.2014.01.017DOI ↗Google Scholar ↗
  39. Raghu, G., & Chang, K. (2004). Idiopathic pulmonary fibrosis: Current trends in management. Clinics in Chest Medicine, 25(4), 627-643.Google Scholar ↗
  40. https://doi.org/10.1016/j.ccm.2004.08.004DOI ↗Google Scholar ↗
  41. Zisman, D. A., Schwarz, M., Anstrom, K. J., Collard, H. R., Flaherty, K. R., & Hunninghake, G. W. (2010b). A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. New England Journal of Medicine, 363(7), 620–628. https://doi.org/10.1056/nejmoa1002110DOI ↗Google Scholar ↗
  42. Han, M. K., Bach, D. S., Hagan, P. G., Yow, E., Flaherty, K. R., Toews, G. B., . . . Martinez, F. J. (2013). Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction. CHEST Journal, 143(6), 1699–1708. https://doi.org/10.1378/chest.12-1594DOI ↗Google Scholar ↗
  43. Harari, S., Elia, D., & Humbert, M. (2017). Pulmonary hypertension in parenchymal lung diseases. CHEST Journal, 153(1), 217–223. https://doi.org/10.1016/j.chest.2017.06.008DOI ↗Google Scholar ↗
Author details
Sathish Krishnan
Division of Pulmonary and Critical Care Medicine, Community Health Network, Indianapolis, Indiana, USA.
✉ Corresponding Author
👤 View Profile →